Cargando…

Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice

Type 2 diabetes is a major public health concern worldwide. Xylobiose (XB) consists of two molecules of d-xylose and is a major disaccharide in xylooligosaccharides that are used as prebiotics. We hypothesized that XB could regulate diabetes-related metabolic and genetic changes via microRNA express...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Eunjin, Lim, Ji Ye, Kim, Eunju, Kim, Yoo-Sun, Shin, Jae-Ho, Seok, Pu Reum, Jung, Sangwon, Yoo, Sang-Ho, Kim, Yuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5188446/
https://www.ncbi.nlm.nih.gov/pubmed/27929393
http://dx.doi.org/10.3390/nu8120791
_version_ 1782487035875950592
author Lim, Eunjin
Lim, Ji Ye
Kim, Eunju
Kim, Yoo-Sun
Shin, Jae-Ho
Seok, Pu Reum
Jung, Sangwon
Yoo, Sang-Ho
Kim, Yuri
author_facet Lim, Eunjin
Lim, Ji Ye
Kim, Eunju
Kim, Yoo-Sun
Shin, Jae-Ho
Seok, Pu Reum
Jung, Sangwon
Yoo, Sang-Ho
Kim, Yuri
author_sort Lim, Eunjin
collection PubMed
description Type 2 diabetes is a major public health concern worldwide. Xylobiose (XB) consists of two molecules of d-xylose and is a major disaccharide in xylooligosaccharides that are used as prebiotics. We hypothesized that XB could regulate diabetes-related metabolic and genetic changes via microRNA expression in db/db mice. For six weeks, C57BL/KsJ-db/db mice received 5% XB as part of the total sucrose content of their diet. XB supplementation improved glucose tolerance with reduced levels of OGTT AUC, fasting blood glucose, HbA1c, insulin, and HOMA-IR. Furthermore, XB supplementation decreased the levels of total triglycerides, total cholesterol, and LDL-C. The expression levels of miR-122a and miR-33a were higher and lower in the XB group, respectively. In the liver, expressions of the lipogenic genes, including, fatty acid synthase (FAS), peroxisome proliferator activated receptor γ (PPARγ), sterol regulatory element-binding protein-1C (SREBP-1C), sterol regulatory element-binding protein-2 (SREBP-2), acetyl-CoA carboxylase (ACC), HMG-CoA reductase (HMGCR), ATP-binding cassette transporter G5/G8 (ABCG5/8), cholesterol 7 alpha-hydroxylase (CYP7A1), and sterol 12-alpha-hydroxylase (CYP8B1), as well as oxidative stress markers, including superoxide dismutase 1 (SOD1), superoxide dismutase 2 (SOD2), glutathione peroxidase (GPX), and catalase, were also regulated by XB supplementation. XB supplementation inhibited the mRNA expressions levels of the pro-inflammatory cytokines, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, interleukin (IL)-6, and monocyte chemoattractant protein (MCP)-1, as well as phosphorylation of c-Jun N-terminal kinase/stress activated protein kinase (JNK/SAPK), p38 mitogen-activated protein kinases (MAPK), and extracellular signal-regulated kinases 1/2 (ERK1/2). These data demonstrate that XB exhibits anti-diabetic, hypolipogenic, and anti-inflammatory effects via regulation of the miR-122a/33a axis in db/db mice.
format Online
Article
Text
id pubmed-5188446
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-51884462017-01-03 Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice Lim, Eunjin Lim, Ji Ye Kim, Eunju Kim, Yoo-Sun Shin, Jae-Ho Seok, Pu Reum Jung, Sangwon Yoo, Sang-Ho Kim, Yuri Nutrients Article Type 2 diabetes is a major public health concern worldwide. Xylobiose (XB) consists of two molecules of d-xylose and is a major disaccharide in xylooligosaccharides that are used as prebiotics. We hypothesized that XB could regulate diabetes-related metabolic and genetic changes via microRNA expression in db/db mice. For six weeks, C57BL/KsJ-db/db mice received 5% XB as part of the total sucrose content of their diet. XB supplementation improved glucose tolerance with reduced levels of OGTT AUC, fasting blood glucose, HbA1c, insulin, and HOMA-IR. Furthermore, XB supplementation decreased the levels of total triglycerides, total cholesterol, and LDL-C. The expression levels of miR-122a and miR-33a were higher and lower in the XB group, respectively. In the liver, expressions of the lipogenic genes, including, fatty acid synthase (FAS), peroxisome proliferator activated receptor γ (PPARγ), sterol regulatory element-binding protein-1C (SREBP-1C), sterol regulatory element-binding protein-2 (SREBP-2), acetyl-CoA carboxylase (ACC), HMG-CoA reductase (HMGCR), ATP-binding cassette transporter G5/G8 (ABCG5/8), cholesterol 7 alpha-hydroxylase (CYP7A1), and sterol 12-alpha-hydroxylase (CYP8B1), as well as oxidative stress markers, including superoxide dismutase 1 (SOD1), superoxide dismutase 2 (SOD2), glutathione peroxidase (GPX), and catalase, were also regulated by XB supplementation. XB supplementation inhibited the mRNA expressions levels of the pro-inflammatory cytokines, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, interleukin (IL)-6, and monocyte chemoattractant protein (MCP)-1, as well as phosphorylation of c-Jun N-terminal kinase/stress activated protein kinase (JNK/SAPK), p38 mitogen-activated protein kinases (MAPK), and extracellular signal-regulated kinases 1/2 (ERK1/2). These data demonstrate that XB exhibits anti-diabetic, hypolipogenic, and anti-inflammatory effects via regulation of the miR-122a/33a axis in db/db mice. MDPI 2016-12-05 /pmc/articles/PMC5188446/ /pubmed/27929393 http://dx.doi.org/10.3390/nu8120791 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lim, Eunjin
Lim, Ji Ye
Kim, Eunju
Kim, Yoo-Sun
Shin, Jae-Ho
Seok, Pu Reum
Jung, Sangwon
Yoo, Sang-Ho
Kim, Yuri
Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice
title Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice
title_full Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice
title_fullStr Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice
title_full_unstemmed Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice
title_short Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice
title_sort xylobiose, an alternative sweetener, ameliorates diabetes-related metabolic changes by regulating hepatic lipogenesis and mir-122a/33a in db/db mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5188446/
https://www.ncbi.nlm.nih.gov/pubmed/27929393
http://dx.doi.org/10.3390/nu8120791
work_keys_str_mv AT limeunjin xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice
AT limjiye xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice
AT kimeunju xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice
AT kimyoosun xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice
AT shinjaeho xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice
AT seokpureum xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice
AT jungsangwon xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice
AT yoosangho xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice
AT kimyuri xylobioseanalternativesweeteneramelioratesdiabetesrelatedmetabolicchangesbyregulatinghepaticlipogenesisandmir122a33aindbdbmice